Silicon Laboratories (NASDAQ:SLAB) Upgraded to "Sell" at StockNews.com

StockNews.com upgraded shares of Silicon Laboratories (NASDAQ:SLAB - Free Report) to a sell rating in a report issued on Friday morning.

A number of other analysts have also recently commented on SLAB. Barclays dropped their price objective on Silicon Laboratories from $120.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday. Stifel Nicolaus lowered their price target on shares of Silicon Laboratories from $160.00 to $135.00 and set a "buy" rating for the company in a report on Tuesday. KeyCorp reduced their price objective on shares of Silicon Laboratories from $150.00 to $115.00 and set an "overweight" rating on the stock in a research note on Tuesday. Morgan Stanley lowered their target price on shares of Silicon Laboratories from $123.00 to $97.00 and set an "equal weight" rating for the company in a research note on Tuesday. Finally, Benchmark reissued a "hold" rating on shares of Silicon Laboratories in a research note on Tuesday. One research analyst has rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $121.50.

Silicon Laboratories Stock Performance

NASDAQ:SLAB traded down $1.55 during mid-day trading on Friday, hitting $112.10. 220,326 shares of the company's stock traded hands, compared to its average volume of 299,355. Silicon Laboratories has a 1 year low of $92.55 and a 1 year high of $154.91. The company has a market cap of $3.64 billion, a PE ratio of -15.15 and a beta of 1.20. The firm's 50 day simple moving average is $112.09 and its 200 day simple moving average is $115.42.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.07. The firm had revenue of $166.00 million during the quarter, compared to the consensus estimate of $165.50 million. Silicon Laboratories had a negative return on equity of 12.60% and a negative net margin of 46.93%. The company's quarterly revenue was down 18.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.48 EPS. On average, research analysts expect that Silicon Laboratories will post -3.41 earnings per share for the current fiscal year.

Insider Buying and Selling at Silicon Laboratories

In other news, SVP Brandon Tolany sold 845 shares of Silicon Laboratories stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $115.00, for a total value of $97,175.00. Following the transaction, the senior vice president now directly owns 43,615 shares of the company's stock, valued at $5,015,725. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 1.72% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. CWM LLC grew its stake in shares of Silicon Laboratories by 185.0% in the second quarter. CWM LLC now owns 8,435 shares of the semiconductor company's stock valued at $933,000 after buying an additional 5,475 shares in the last quarter. Natixis acquired a new position in shares of Silicon Laboratories during the first quarter worth $647,000. Vanguard Group Inc. boosted its stake in shares of Silicon Laboratories by 0.7% in the first quarter. Vanguard Group Inc. now owns 3,489,160 shares of the semiconductor company's stock valued at $501,462,000 after purchasing an additional 24,997 shares during the period. SG Americas Securities LLC grew its holdings in Silicon Laboratories by 284.6% during the 2nd quarter. SG Americas Securities LLC now owns 7,076 shares of the semiconductor company's stock valued at $783,000 after purchasing an additional 5,236 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its stake in Silicon Laboratories by 31.7% during the 1st quarter. Russell Investments Group Ltd. now owns 52,578 shares of the semiconductor company's stock worth $7,557,000 after buying an additional 12,667 shares during the period.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.